Down syndrome (DS), or trisomy 21, is a common disorder associated with several complex
clinical phenotypes. Although several hypotheses have been put forward, it is unclear as to …

Individuals with Down syndrome over age 40 years are at risk for developing dementia of
the Alzheimer type and have evidence for chronic oxidative stress. There is a paucity of …

Overexpression of the amyloid precursor protein (APP) gene on chromosome 21 in Down
syndrome (DS) has been linked to increased brain amyloid levels and early-onset Alzheimer’s …

Increasing evidence is implicating mitochondrial dysfunction as a central factor in the etiology
of Alzheimer’s disease (AD). The most significant risk factor in AD is advanced age and an …

Introduction Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD)
neuropathology and dementia early in life. Blood biomarkers of AD neuropathology would be …

Down syndrome (DS) provides a model for studying important aspects of Alzheimer disease
(AD). Chromosome 21 contains several genes that have been implicated in …

The objective of this study was to determine the association of seizures and cognitive decline
in adults with Down syndrome (DS) and Alzheimer's-type dementia. A retrospective data …

People with Down syndrome (DS) are at high risk for developing Alzheimer disease (AD)
with age. Typically, by age 40 years, most people with DS have sufficient neuropathology for …

Background Due to trisomy of chromosome 21 and the resultant extra copy of the amyloid
precursor protein gene, nearly all adults with Down syndrome develop Alzheimer's disease …

Introduction Microglial cells play an important role in the development of Alzheimer's disease
(AD). People with Down syndrome (DS) inevitably develop AD neuropathology (DSAD) by …